{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:46:04Z","timestamp":1789663564363,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":860,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Alexandra Yeo Grant in Benign Hematology","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1002\/rth2.12354","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T10:32:56Z","timestamp":1590834776000},"page":"1046-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Desmopressin responsiveness by age in type 1 von Willebrand disease"],"prefix":"10.1016","volume":"4","author":[{"given":"Nicola","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane","family":"Nisenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Teitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantep","family":"Angchaisuksiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1002\/rth2.12354_bb0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1002\/rth2.12354_bb0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost [Internet]"},{"issue":"4","key":"10.1002\/rth2.12354_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med [Internet]"},{"issue":"Suppl 1","key":"10.1002\/rth2.12354_bb0025","first-page":"150","article-title":"Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor","volume":"26","author":"Ciavarella","year":"1996","journal-title":"Haemostasis [Internet]"},{"issue":"4","key":"10.1002\/rth2.12354_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0037-1613878","article-title":"Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor","volume":"83","author":"Grossmann","year":"2000","journal-title":"Thromb Haemost [Internet]"},{"issue":"4","key":"10.1002\/rth2.12354_bb0035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1538-7836.2003.00190.x","article-title":"Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1002\/rth2.12354_bb0040","first-page":"276","article-title":"Response to 1\u2010deamino\u20108\u2010d\u2010arginine vasopressin in von Willebrand disease","volume":"24","author":"Lusher","year":"1994","journal-title":"Haemostasis [Internet]"},{"issue":"6","key":"10.1002\/rth2.12354_bb0045","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood [Internet]"},{"issue":"4","key":"10.1002\/rth2.12354_bb0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor","volume":"66","author":"Mannucci","year":"1985","journal-title":"Blood [Internet]"},{"issue":"2","key":"10.1002\/rth2.12354_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V67.2.465.465","article-title":"DDAVP in type IIa von Willebrand's disease","volume":"67","author":"Gralnick","year":"1986","journal-title":"Blood [Internet]"},{"issue":"977","key":"10.1002\/rth2.12354_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/pgmj.2006.052118","article-title":"How do you treat bleeding disorders with desmopressin?","volume":"83","author":"Ozg\u00f6nenel","year":"2007","journal-title":"Postgrad Med J [Internet]"},{"issue":"1","key":"10.1002\/rth2.12354_bb0065","first-page":"39","article-title":"Von Willebrand factor in Italian centenarians","volume":"88","author":"Coppola","year":"2003","journal-title":"Haematologica [Internet]"},{"issue":"5","key":"10.1002\/rth2.12354_bb0070","first-page":"636","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Natalia"},{"issue":"2","key":"10.1002\/rth2.12354_bb0075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.24962","article-title":"Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: a two decade study","volume":"93","author":"Abou\u2010Ismail","year":"2018","journal-title":"Am J Hematol [Internet]"},{"issue":"7","key":"10.1002\/rth2.12354_bb0080","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jth.12586","article-title":"von Willebrand disease and aging: an evolving phenotype","volume":"12","author":"Sanders","year":"2014","journal-title":"J Thromb Haemost [Internet]"},{"issue":"6","key":"10.1002\/rth2.12354_bb0085","first-page":"2032","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Response"},{"issue":"6","key":"10.1002\/rth2.12354_bb0090","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/pr.2014.131","article-title":"Age at hormonal onset of puberty based on luteinizing hormone, inhibin B, and body composition in preadolescent US girls","volume":"76","author":"Addo","year":"2014","journal-title":"Pediatr Res [Internet]"},{"issue":"3","key":"10.1002\/rth2.12354_bb0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti\u2010M\u00fcllerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update [Internet]"},{"issue":"3","key":"10.1002\/rth2.12354_bb0100","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201502030","article-title":"Perimenopause","volume":"162","author":"McNamara","year":"2015","journal-title":"Ann Internal Med"},{"issue":"3","key":"10.1002\/rth2.12354_bb0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V63.3.657.657","article-title":"Estrogen stimulates von Willebrand factor production by cultured endothelial cells","volume":"63","author":"Harrison","year":"1984","journal-title":"Blood [Internet]"},{"issue":"3","key":"10.1002\/rth2.12354_bb0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-9343(82)90729-X","article-title":"Estrogens and surgery in women with von Willebrand's disease","volume":"73","author":"Alperin","year":"1982","journal-title":"Am J Med [Internet]"},{"issue":"2","key":"10.1002\/rth2.12354_bb0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GRF.0000000000000356","article-title":"Contraceptive management for women who are at high risk of thrombosis","volume":"61","author":"Gray","year":"2018","journal-title":"Clin Obstet Gynecol [Internet]"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12354","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12354","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12354","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:18:47Z","timestamp":1762863527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922020660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2475037922020660"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12354","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desmopressin responsiveness by age in type 1 von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}